CGMs: GLP-1 Weight Loss At A Fraction Of The Cost | with Colin Rogers
“We show…very similar weight loss outcomes to GLP1 in a similar timeframe at a fraction of the cost, but sustainable through behavior change." - Colin Rogers
Colin Rogers, VP at Signos, joined me for episode 200! On this special episode, we talked about something I’m very passionate and vocal about: weight loss for everybody.
Signos combines continuous glucose monitors (CGMs), our phones, and AI to track longitudinal data and help educate and prompt members to make better health decisions. If you’re into personalized population health, then this is the episode for you!
On one of our earliest…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.